mous
model
import
tool
studi
pathogenesi
infecti
diseas
preclin
evalu
vaccin
therapi
wide
varieti
human
pathogen
use
genet
defin
inbr
mous
strain
human
mice
gene
knockout
mice
allow
research
commun
explor
pathogen
caus
diseas
defin
role
specif
host
gene
either
control
promot
diseas
identifi
potenti
target
prevent
treatment
wide
rang
infecti
agent
review
discuss
sever
commonli
use
mous
model
system
well
new
resourc
collabor
cross
model
studi
infecti
diseas
clin
ther
past
centuri
advanc
develop
vaccin
antibioticsantivir
infect
control
measur
result
major
reduct
public
health
burden
infecti
diseas
howev
despit
advanc
infecti
agent
continu
caus
signific
morbid
mortal
human
popul
well
econom
disrupt
atrisk
commun
challeng
associ
infecti
diseas
illustr
emerg
pathogen
hiv
recent
outbreak
zika
viru
zikv
ebola
viru
also
continu
threat
pathogen
season
influenza
viru
hepat
c
viru
hcv
dengu
viru
malaria
furthermor
emerg
antibioticor
drugresist
microorgan
virus
complic
treatment
strategi
enhanc
risk
pose
infecti
diseas
due
threat
ongo
need
new
strategi
prevent
pathogen
transmiss
well
develop
new
vaccin
andor
therapeut
agent
howev
develop
new
infect
control
strategi
requir
indepth
understand
target
pathogen
biolog
diseas
pathogenesi
well
appropri
system
test
safeti
efficaci
new
treatment
vaccin
mani
pathogen
much
understand
pathogen
biolog
diseas
pathogenesi
come
direct
clinic
observ
affect
patient
popul
also
case
vaccin
antimicrobialantivir
treatment
clinic
trial
assess
safeti
efficaci
data
provid
signific
insight
correl
protect
diseas
pathogenesi
human
popul
furthermor
wellcontrol
challeng
studi
provid
import
insight
host
respons
pathogen
season
influenza
virus
rhinovirus
howev
sever
factor
confound
limit
abil
studi
infecti
diseas
human
human
vari
greatli
suscept
certain
pathogen
individu
may
highli
suscept
wherea
other
develop
mild
diseas
remain
asymptomat
exampl
small
fraction
west
nile
viruseinfect
individu
becom
symptomat
individu
vari
greatli
suscept
common
pathogen
human
noroviru
variat
confound
analysi
human
driven
factor
human
pathogen
genet
variat
underli
health
issu
demograph
factor
age
sex
furthermor
previou
pathogen
exposur
gener
result
immunemedi
protect
instanc
also
drive
immun
patholog
illustr
dengu
hemorrhag
feverdengu
shock
syndrom
although
possibl
control
mani
variabl
confound
factor
eg
pathogen
dose
previou
exposur
relat
pathogen
difficult
control
natur
infect
addit
confound
effect
diseas
variat
human
popul
difficult
perform
mechanist
analysi
access
affect
tissu
human
due
ethic
limit
although
problem
sometim
overcom
use
primari
human
cell
difficult
accur
model
complex
system
interact
pathogen
host
use
simplifi
cell
cultur
system
due
limit
associ
studi
infecti
diseas
human
research
commun
reli
anim
model
studi
pathogenesi
infect
platform
test
efficaci
safeti
experiment
vaccin
therapi
move
human
studi
model
provid
sever
advantag
includ
abil
control
mani
factor
cofound
analysi
human
viral
dose
underli
diseas
state
also
allow
much
invas
studi
would
possibl
human
wide
rang
speci
use
experiment
model
hostpathogen
interact
includ
nonvertebr
model
eg
caenorhabd
elegan
fish
eg
zebrafish
domest
livestock
eg
pig
cattl
system
provid
import
insight
pathogen
biolog
zoonot
transmiss
hostepathogen
interact
model
offer
specif
advantag
exampl
c
elegan
short
welldefin
life
cycl
easili
manipul
genet
level
transpar
worm
easili
visual
infect
wide
varieti
clinic
relev
bacteri
fungal
pathogen
zebrafish
danio
rerio
also
experiment
tractabl
visual
transpar
mount
innat
immun
respons
similar
seen
human
trait
made
zebrafish
model
particularli
use
visual
host
inflammatori
respons
studi
role
specif
pathogen
determin
host
factor
regul
infect
sever
clinic
relev
bacteri
viral
pathogen
includ
mycobacterium
lepra
pseudomona
aeruginosa
shigella
flexneri
chikungunya
viru
howev
bulk
laboratori
studi
reli
limit
number
laboratori
speci
includ
mice
rat
guinea
pig
ferret
nonhuman
primat
nhp
studi
host
respons
specif
pathogen
choic
specif
model
system
studi
given
pathogen
driven
number
factor
includ
permiss
infect
physiolog
conserv
human
reproduc
eas
manipul
safeti
andor
cost
howev
also
gener
true
model
organ
perfectli
reproduc
respons
infect
seen
human
mani
case
differ
anim
model
use
complementari
way
address
specif
question
relat
pathogeninduc
diseas
exampl
nhp
speci
due
physiolog
similar
evolutionari
conserv
human
commonli
use
studi
viral
pathogen
ebola
viru
middl
eastern
respiratori
syndrom
coronaviru
merscov
influenza
virus
howev
due
factor
expens
associ
nhp
studi
well
limit
avail
long
reproduct
time
difficulti
manipul
nhp
genet
level
model
system
use
studi
pathogen
nice
illustr
influenza
viru
nhp
use
studi
viral
pathogenesi
howev
ferret
highli
permiss
wide
varieti
human
respiratori
virus
includ
influenza
viru
ferret
respiratori
tract
anatom
similar
human
therefor
viral
transmiss
pathogenesi
studi
often
perform
ferret
model
addit
reproduc
mani
aspect
human
influenza
pathogenesi
lower
cost
readili
access
nhp
furthermor
although
mice
gener
use
studi
influenza
viru
transmiss
histor
prefer
model
system
studi
influenzaspecif
immun
due
part
avail
welldefin
immun
reagent
genespecif
knockout
mice
although
differ
anim
model
appropri
studi
specif
pathogen
studi
specif
aspect
pathogen
biolog
diseas
pathogenesi
laboratori
mous
one
commonli
use
anim
model
studi
infecti
diseas
domin
mous
model
system
driven
sever
factor
includ
rel
low
cost
eas
hous
rapid
reproduct
time
larg
litter
size
importantli
avail
inbr
mous
strain
everi
mous
strain
essenti
genet
ident
well
genet
modifi
mice
lack
specif
host
gene
allow
scientif
research
commun
studi
specif
host
gene
affect
respons
pathogen
challeng
also
promot
understand
host
immun
system
role
protect
pathogen
challeng
mediat
vaccineinduc
immun
mous
model
limit
includ
physiolog
differ
limit
well
mice
reproduc
key
aspect
hostepathogen
interact
effici
influenza
viru
transmiss
genet
differ
mice
human
also
interfer
pathogen
abil
replic
caus
humanlik
diseas
outcom
mice
howev
despit
limit
mous
model
provid
number
advantag
studi
hostepathogen
interact
furthermor
discuss
later
instanc
standard
mous
model
use
work
specif
pathogen
avail
genet
modifi
mice
human
mous
model
genet
divers
mous
popul
sometim
use
overcom
difficulti
allow
mice
use
tool
studi
hostepathogen
interact
therefor
given
import
laboratori
mous
model
system
studi
infecti
diseas
remaind
review
focus
major
type
mous
model
util
studi
infecti
diseas
figur
note
earlier
one
major
advantag
provid
inbr
mous
strain
reproduc
therefor
inbr
strain
balbc
mice
use
studi
pathogen
tropism
replic
kinet
compar
virul
differ
pathogen
strain
genet
ident
set
mice
enabl
investig
assess
experiment
reproduc
within
laboratori
control
effect
host
genet
respons
infect
infecti
diseas
studi
avail
inbr
strain
allow
investig
perform
replic
studi
compar
result
laboratori
investig
differ
pathogen
alter
pathogen
dose
differ
treatment
affect
genet
ident
individu
anoth
advantag
provid
clinic
therapeut
inbr
mous
strain
fact
wide
varieti
immun
reagent
exist
quantifi
host
immun
respons
includ
pathogenspecif
major
histocompat
complexerestrict
tcell
epitop
tetram
reagent
enabl
quantif
pathogenspecif
cell
infect
vaccin
specif
mous
genet
background
therefor
inbr
mous
strain
also
invalu
resourc
studi
tcell
respons
virus
lymphocyt
choriomening
viru
influenza
viru
system
instrument
advanc
understand
immun
system
addit
provid
reproduc
wellcharacter
model
studi
biolog
infect
pathogenspecif
immun
avail
genespecif
knockout
defin
mous
genet
background
eg
use
research
commun
year
studi
role
specif
host
gene
respons
infect
compar
wildtyp
mice
versu
mice
knock
specif
gene
genet
background
investig
test
specif
effect
gene
pathogeninduc
diseas
immun
control
effect
remaind
genom
although
mani
medic
relev
pathogen
capabl
replic
caus
diseas
standard
laboratori
mous
strain
mani
pathogen
includ
virus
zikv
human
noroviru
crimeancongo
hemorrhag
fever
viru
replic
poorli
andor
fail
caus
diseas
standard
mous
strain
subset
pathogen
possibl
use
mice
lack
key
aspect
host
immun
system
rang
broadli
immunodefici
mous
strain
scid
knockout
mice
lack
function
b
cell
mice
lack
specif
immun
pathway
type
interferon
system
util
broadli
immunodefici
model
studi
infecti
diseas
illustr
human
noroviru
pathogen
anim
model
lack
demonstr
viru
replic
mice
lack
function
adapt
immun
system
furthermor
mice
specif
lack
function
type
interferon
system
use
develop
model
number
import
human
virus
includ
zikv
crimeancongo
hemorrhag
fever
viru
dengu
viru
yellow
fever
viru
exampl
zikv
caus
major
epidem
associ
sever
birth
defect
review
elsewher
fail
replic
effici
wildtyp
mice
due
viru
inabl
effici
antagon
signal
protein
mous
type
interferon
system
overcom
limit
investig
taken
advantag
mice
lack
function
type
interferon
system
due
ablat
type
interferon
receptor
essenti
interferon
signal
molecul
unlik
wildtyp
mice
interferondefici
mous
strain
suscept
zikv
infect
use
platform
studi
pathogenesi
zikvinduc
birth
defect
test
potenti
zikv
therapi
although
immunodefici
mice
use
system
studi
virus
zikv
instanc
necessari
introduc
specif
human
gene
engraft
human
cell
organ
system
mous
gener
infecti
diseas
model
case
mice
nonpermiss
infect
pathogen
introduct
one
small
number
provir
gene
mous
entri
receptor
may
suffici
allow
pathogen
replic
diseas
type
genet
human
mice
use
number
virus
includ
measl
viru
merscov
case
merscov
mous
cell
nonpermiss
viral
infect
host
rang
restrict
overcom
express
human
version
viral
receptor
protein
dipeptidyl
peptidas
iv
two
amino
acid
differ
mous
human
respons
differ
receptor
function
express
fulllength
human
molecul
mous
introduc
human
amino
acid
chang
mous
molecul
make
mice
permiss
merscov
replic
although
simpli
express
singl
human
gene
suffici
make
mice
permiss
merscov
model
still
necessari
allow
viru
adapt
mous
achiev
full
virul
case
measl
viru
necessari
introduc
human
receptor
molecul
also
ablat
compon
host
antivir
respons
make
mice
fulli
permiss
infect
altern
virus
zikv
block
viral
replic
mous
due
inabl
zikv
effici
antagon
compon
type
interferon
signal
pathway
replac
mous
gene
human
gene
use
gener
fulli
immunocompet
mous
model
zikv
infect
diseas
although
genet
human
mous
strain
power
tool
model
infect
viral
pathogen
virus
hcv
sever
gene
regul
host
rang
make
difficult
fulli
recapitul
human
factor
promot
pathogen
replic
diseas
either
standard
genet
human
mice
furthermor
differ
mous
human
immun
system
may
limit
util
standard
modifi
mous
strain
model
studi
host
immun
respons
diseas
pathogenesi
overcom
problem
research
commun
use
mice
engraft
human
tissu
model
human
respons
infect
human
tissu
xenograft
mice
take
advantag
fact
mice
lack
function
adapt
immun
system
eg
scid
knockout
mice
permiss
engraft
human
immun
cell
remov
mous
gene
common
gamma
chain
receptor
result
improv
engraft
model
use
studi
multipl
aspect
host
innat
adapt
immun
respons
also
engraft
solid
organ
tissu
human
furthermor
immun
cell
tissu
individu
use
gener
cohort
human
mice
possibl
test
respons
set
individu
carri
tissu
genet
background
although
detail
descript
differ
type
human
mous
model
method
use
develop
beyond
scope
present
review
refer
reader
sever
recent
review
nice
summar
current
state
xenograft
mous
develop
mice
xenograft
human
immun
system
use
studi
pathogenesi
wide
rang
infecti
agent
includ
plasmodium
falciparum
malaria
mycobacterium
tuberculosi
dengu
viru
influenza
viru
model
particularli
use
studi
hiv
includ
analysi
viral
host
factor
promot
viral
replic
hiv
interact
host
immun
respons
platform
test
therapeut
approach
control
cure
hiv
infect
although
major
studi
use
xenograft
mice
focus
human
immun
cell
model
also
use
evalu
pathogen
interact
solid
organ
human
liver
xenograft
mice
shown
support
replic
hepat
virus
b
c
e
model
use
studi
pathogenesi
virusinduc
liver
injuri
platform
evalu
potenti
therapi
treat
acut
chronic
hcv
hepat
b
viru
infect
likewis
human
intestin
xenograft
model
use
studi
entamoeba
histolytica
infect
lung
xenograft
shown
support
nipah
viru
infect
despit
util
human
xenograft
model
limit
includ
issu
engraft
efficiencytissu
reject
inabl
fulli
recapitul
human
immun
respons
antigenspecif
antibodi
respons
howev
despit
limit
model
system
repres
import
set
tool
model
pathogen
interact
human
cell
tissu
vivo
model
continu
improv
like
gain
even
greater
use
within
infecti
diseas
research
commun
discuss
earlier
one
major
reason
inbr
mous
strain
genet
modifi
deriv
power
system
studi
infecti
diseas
reproduc
abil
use
set
genet
ident
anim
individu
inbr
mous
strain
eg
allow
replic
experi
comparison
respons
across
differ
treatment
eg
pathogen
dose
strain
therapi
howev
relianc
one
even
mous
strain
mean
investig
evalu
pathogen
infect
limit
number
genet
background
unlik
recapitul
phenotyp
divers
seen
within
genet
divers
human
popul
upon
pathogen
exposur
therefor
model
pathogen
interact
genet
divers
popul
number
investig
use
genet
divers
mous
popul
collabor
cross
cc
cc
panel
recombin
inbr
mous
strain
design
model
genet
divers
present
human
popul
promot
identif
polymorph
host
gene
contribut
phenotyp
variat
across
popul
cc
deriv
parent
mous
strain
includ
classic
laboratori
strain
aj
nodshiltj
nzohiltj
well
wild
deriv
strain
mu
musculu
subspeci
domesticu
wsbeij
casteneu
cast
eij
musculu
pwkphj
provid
major
genet
divers
found
cc
founder
strain
intercross
use
funnel
breed
system
produc
progeni
mice
genet
mosaic
origin
founder
strain
mice
bred
homozygos
creat
recombin
inbr
cc
mous
strain
current
inbr
cc
strain
avail
use
scientif
commun
http
csbiounceduccstatusindexpi
cc
strain
inbr
allow
investig
perform
type
compar
studi
across
reproduc
set
anim
conduct
standard
inbr
strain
ie
howev
cc
strain
possess
uniqu
combin
genet
materi
origin
founder
strain
cc
strain
often
exhibit
uniqu
phenotyp
observ
origin
founder
strain
result
develop
new
mous
model
better
reproduc
specif
aspect
human
diseas
figur
furthermor
compar
phenotyp
cc
strain
investig
test
host
genet
variat
affect
specif
phenotyp
includ
respons
pathogen
challeng
map
specif
genet
loci
respons
variat
cc
design
map
quantit
trait
loci
qtl
associ
phenotyp
variat
across
investig
select
cc
strain
strain
desir
phenotyp
develop
new
model
system
altern
investig
take
advantag
phenotyp
variat
cc
perform
genet
map
studi
identifi
studi
polymorph
host
gene
associ
variat
infect
outcom
cc
strain
sever
group
taken
advantag
capabl
map
qtl
associ
variat
host
respons
infect
develop
cc
sever
group
use
incomplet
inbr
popul
cc
mice
known
precc
assess
variat
suscept
viral
bacteri
fungal
pathogen
first
studi
examin
infecti
diseas
suscept
precc
durrant
et
al
analyz
panel
precc
line
variat
suscept
aspergillu
fumigatu
studi
found
high
level
variat
surviv
time
across
precc
line
map
sever
qtl
associ
fumigatu
suscept
precc
well
fulli
inbr
cc
strain
also
use
studi
impact
host
genet
variat
bacteri
infect
vere
et
al
evalu
precc
line
variat
suscept
klebsiella
pneumonia
identifi
qtl
associ
variat
k
pneumonia
surviv
second
studi
zhang
et
al
evalu
variat
suscept
salmonella
enterica
challeng
panel
fulli
inbr
cc
strain
identifi
sever
genet
loci
associ
variat
bacteri
load
sever
studi
also
use
either
precc
cross
fulli
inbr
cc
strain
map
qtl
associ
variat
virusinduc
diseas
studi
detail
maurizio
et
al
ferri
et
al
analysi
identifi
addit
genet
loci
associ
variat
sarscoveinduc
diseas
identifi
valid
gene
adaptor
contributor
variat
sarscoveinduc
diseas
suscept
addit
util
cc
identifi
polymorph
host
gene
regul
pathogen
suscept
investig
taken
advantag
high
level
phenotyp
variat
cc
strain
develop
improv
model
pathogeninduc
diseas
perhap
best
illustr
studi
rasmussen
et
al
use
cc
develop
new
mous
model
ebola
viruseinduc
hemorrhag
diseas
ebola
viru
caus
wide
rang
symptom
human
includ
hemorrhag
diseas
howev
although
use
mouseadapt
ebola
viru
standard
mous
strain
use
studi
diseas
pathogenesi
test
vaccinestherapi
model
fulli
reproduc
diseas
sign
seen
infect
human
rasmussen
et
al
evalu
panel
cross
fulli
inbr
cc
strain
suscept
challeng
mouseadapt
ebola
viru
studi
found
high
level
variat
diseas
suscept
includ
identif
cc
strain
develop
sever
diseas
hemorrhag
sign
liver
damag
studi
sever
group
identifi
cc
strain
exhibit
novel
suscept
profil
wide
rang
pathogen
includ
tuberculosi
west
nile
viru
sarscov
influenza
viru
result
indic
take
advantag
genet
divers
present
cc
investig
develop
novel
model
pathogeninduc
diseas
close
repres
diseas
phenotyp
observ
human
popul
furthermor
mous
strain
novel
diseas
phenotyp
identifi
possibl
identifi
genet
loci
respons
novel
diseas
outcom
gain
addit
insight
mechan
underli
diseas
pathogenesi
anim
model
continu
import
resourc
investig
mechan
underli
infecti
diseas
pathogenesi
platform
test
potenti
vaccin
therapi
mous
model
particularli
import
resourc
studi
infect
wide
rang
human
pathogen
wide
use
preclin
screen
vaccinestherapi
due
reproduc
low
cost
eas
experiment
manipul
although
mous
model
appropri
studi
aspect
pathogeninduc
diseas
use
genet
modifi
anim
human
mice
allow
investig
studi
pathogen
replic
effici
speci
human
chimpanze
eg
hcv
perform
mechanist
studi
conduct
human
furthermor
avail
genet
divers
mous
resourc
cc
allow
investig
test
host
genet
divers
affect
respons
infect
also
take
advantag
phenotyp
divers
resourc
develop
model
system
better
reproduc
aspect
pathogeninduc
diseas
seen
human
